The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding.
The conformational flexibility of target proteins continues to be a major challenge in accurate modeling of protein-inhibitor interactions. A fundamental issue, yet to be clarified, is whether the observed conformational changes are controlled by the protein or induced by the inhibitor. Although the concept of induced fit has been widely adopted for describing the structural changes that accompany ligand binding, there is growing evidence in support of the dominance of proteins' intrinsic dynamics which has been evolutionarily optimized to accommodate its functional interactions. The wealth of structural data for target proteins in the presence of different ligands now permits us to make a critical assessment of the balance between these two effects in selecting the bound forms. We focused on three widely studied drug targets, HIV-1 reverse transcriptase, p38 MAP kinase, and cyclin-dependent kinase 2. A total of 292 structures determined for these enzymes in the presence of different inhibitors and unbound form permitted us to perform an extensive comparative analysis of the conformational space accessed upon ligand binding, and its relation to the intrinsic dynamics before ligand binding as predicted by elastic network model analysis. Our results show that the ligand selects the conformer that best matches its structural and dynamic properties among the conformers intrinsically accessible to the protein in the unliganded form. The results suggest that simple but robust rules encoded in the protein structure play a dominant role in predefining the mechanisms of ligand binding, which may be advantageously exploited in designing inhibitors.
Bakan
Ahmet
A
Department of Computational Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Bahar
Ivet
I
D000465:Algorithms; D020134:Catalytic Domain; D051357:Cyclin-Dependent Kinase 2 / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008024:Ligands; D008958:Models, Molecular; D011485:Protein Binding; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D013329:Structure-Activity Relationship; D013816:Thermodynamics; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism
D004791:Enzyme Inhibitors; D008024:Ligands; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2; D048051:p38 Mitogen-Activated Protein Kinases; C514824:reverse transcriptase, Human immunodeficiency virus 1; D054303:HIV Reverse Transcriptase
Curr Opin Struct Biol. 2003 Dec;13(6):748-57
14675554
J Mol Biol. 1999 Apr 16;287(5):821-8
10222191
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2327-32
9122194
Structure. 2007 Sep;15(9):1040-52
17850744
Curr Opin Struct Biol. 2008 Apr;18(2):178-84
18302984
J Mol Biol. 2004 Mar 12;337(1):209-25
15001363
Curr Opin Struct Biol. 2007 Dec;17(6):633-40
18024008
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13829-34
18772387
Science. 2006 Apr 14;312(5771):224-8
16614210
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11182-7
18678900
Protein Eng. 2001 Jan;14(1):1-6
11287673
Biophys J. 2001 Jan;80(1):505-15
11159421
FEBS Lett. 2006 Oct 2;580(22):5130-6
16962102
J Mol Biol. 2009 May 8;388(3):644-58
19324058
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12730-5
16129832
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10901-6
16829580
Structure. 2008 Feb;16(2):321-30
18275822
Structure. 2008 May;16(5):736-46
18462678
J Mol Biol. 2000 Aug 25;301(4):1029-39
10966802
J Am Chem Soc. 2005 Jul 6;127(26):9632-40
15984891
Protein Sci. 2007 Jan;16(1):43-51
17123961
Proteins. 2002 Oct 1;49(1):61-70
12211016
Protein Eng. 1999 Sep;12(9):713-20
10506280
J Am Chem Soc. 2005 Dec 14;127(49):17253-60
16332074
Annu Rev Biophys Biomol Struct. 2006;35:115-33
16689630
PLoS Comput Biol. 2008 Apr 11;4(4):e1000060
18404207
Bioinformatics. 2006 Nov 1;22(21):2619-27
16928735
J Med Chem. 2005 Jun 30;48(13):4432-43
15974595
Bioinformatics. 2009 Mar 1;25(5):606-14
19147661
Science. 2008 Jun 13;320(5882):1471-5
18556554
Science. 1992 Jun 26;256(5065):1783-90
1377403
J Med Chem. 2008 Jun 26;51(12):3499-506
18517186
J Am Chem Soc. 2007 Apr 11;129(14):4158-9
17367145
Phys Rev Lett. 2006 Feb 24;96(7):078104
16606146
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18908-13
16354836
Nature. 2007 Oct 25;449(7165):1078-82
17960247
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6353-8
17395714
Curr Opin Struct Biol. 1999 Apr;9(2):164-9
10322205
Nat Rev Drug Discov. 2003 Sep;2(9):717-26
12951578
J Mol Biol. 1999 Jan 22;285(3):1023-37
9887265